We use cookies to give you the best online experience. Please let us know if you agree to all of these cookies. I AGREE BICYCLE PHARMACEUTICALS PUBLICATIONS INVESTORS & MEDIA CONTACT US About Approach Programs Beyond Oncology Patients Careers We didn’t wait for the next advance against cancer. WE CREATED IT. VIEW ALL NEWS News NOVEMBER 11, 2021 Bicycle Therapeutics to Participate in Upcoming Investor Conferences SEE US ON TWITTER Social Media @Bicycle_tx NOVEMBER 15, 2021 Our COO Michael Skynner will be presenting at the TIDES Europe #conference today at 11.15 CET. He will present on r… http://SBLSpnB7OZ Our Programs We are focused on developing two categories of Bicycles against our oncology targets: Our Technology Learn about our revolutionary Bicycle technology Beyond Oncology Bicycle programs outside of cancer Privacy Policy Contact © Bicycle Therapeutics

BICYCLE PHARMACEUTICALS PUBLICATIONS INVESTORS & MEDIA CONTACT US About Approach Programs Beyond Oncology Patients Careers About Us Bicycle Therapeutics is developing a brand new class of small, chemically synthesized medicines called Bicycles. To redefine what’s possible for people with cancer and other diseases. LEARN MORE We were founded in 2009 to convert innovative Bicycles into transformative medicines for life-altering diseases. Our proprietary phage display screening platform is based on novel science first conceived in the laboratory of Sir Greg Winter, winner of the Nobel Prize in Chemistry in 2018 for pioneering work in phage display. We are a transatlantic company, headquartered in the vibrant life science cluster of Cambridge, U.K., with key oncology functions and members of our leadership team located in the biotech hub of Boston, Mass., U.S.A. WATCH VIDEO We are experienced leaders who are driven by a common goal – to develop a novel class of therapies for diseases that are underserved by existing therapeutics. JOIN US Leadership Kevin Lee, Ph.D., MBA Chief Executive Officer Lee Kalowski, MBA President and Chief Financial Officer Nigel Crockett, Ph.D. Chief Business Officer Nick Keen, Ph.D. Chief Scientific Officer Michael Skynner, Ph.D. Chief Operating Officer Dominic Smethurst, MA, MBChB, MRCP, MFPM Chief Medical Officer Zafar Qadir General Counsel Board of Directors Pierre Legault, MBA, CPA Chairman Janice Bourque, MBA Director Jose-Carlos Gutierrez-Ramos, Ph.D. Director Veronica Jordan, Ph.D. Director Richard N. Kender, MBA Director Kevin Lee, Ph.D., MBA Director Sir Greg Winter, FRS Co-founder and Director Scientific Advisory Board Sir Keith Peters, GBE, Sc.D., FRCP, FRS, FMedSci Garret FitzGerald, M.D., FRS Jane Grogan, Ph.D Caetano Reis e Sousa, DPhil, FRS, FMedSci Geoffrey Shapiro, M.D., Ph.D. Charles Swanton, M.D., Ph.D., FRS, FMedSci, FRCP Sir Greg Winter, Ph.D., FRS Privacy Policy Contact © Bicycle Therapeutics